![\"Risultati](\"https:\/\/media.glassdoor.com\/l\/3879\/boston-consulting-office.jpg\")
Of\u00a0Aboutpharma Online editorial staff<\/a>\u00a0–\u00a0July 27, 2017 \u2013 Aboutpharma<\/span><\/a><\/span><\/p>\nOn the podium of Italian companies that create more value for their shareholders is a pharmaceutical company,\u00a0Register<\/strong>, which ranks second in the ranking drawn up by\u00a0The Boston Consulting Group<\/strong>\u00a0on performance in terms of\u00a0profitability<\/strong>\u00a0of listed securities.<\/p>\n Recordati is among the companies present in the Ftse Mib 40, with 42% of\u00a0Total Shareholder Return<\/strong>(Tsr), the index used by the global consultancy firm to develop its assessments of the ability to create value. The data emerges from the study \u201cHow Top Value Creators Outpace the Market \u2013 For Decades<\/strong>\u201d, developed to analyze the TSR of almost 2,500 companies worldwide for the period 2012-2016. In first place in Italy is Brembo (automotive, 58%) and third, Leonardo (36%).<\/p>\n The research also reveals an elite nine companies that have consistently outperformed their industry average over the past two decades. Seven of these are American, of which two are active in the pharma sector (Gilead Sciences and Celgene<\/strong>) and one in the healthcare sector (UnitedHealth Group).<\/p>\n Rankings 2017<\/span><\/a><\/p>\n Related news:\u00a0Recordati buys heart medicines from Astrazeneca<\/span><\/a><\/p>\n The Albissola-based company Esi Farmaceutica passes to the giant Recordati<\/span><\/a><\/p>\n